Dr. Pinak B. Shah, MD

Dr. Shah practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Shah's NPI, 1750371480, was assigned on October 25, 2005. Dr. Shah graduated from Perelman School of Med at the University of Pennsylvania in 1994. Dr. Shah holds Massachusetts license 150869.

Dr. Shah's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Shah's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Shah is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Shah to 3 more hospitals, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Shah is licensed in Massachusetts.

CMS data shows 982 Medicare services from Dr. Shah across 14 procedure codes in 2024, for 494 Medicare patients. Medicare paid $168,854 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 494 Medicare patients who saw Dr. Shah in 2024. The largest group is 75 to 84, with 205 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 77, with 43% women.

In 2024, Dr. Shah wrote 392 Medicare Part D claims for 65 patients. 85% of them were for generic drugs. CMS names the drug for 285 of them, across 10 drugs with 11 or more claims each, at $39,955 in total drug cost. In 2023, CMS named 288 claims across 11 drugs.

Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shah as offering telehealth. CMS counts 38 procedures of coronary angioplasty and stenting by Dr. Shah, more than 74% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 114 papers to Dr. Shah, published from 2013 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis and Aortic Valve. Dr. Shah has published most often in Circ Cardiovasc Interv. Dr. Shah's most frequent co-authors are Piotr S. Sobieszczyk, MD, Marc Pelletier, MD and Patrick T. O'Gara, MD.

Dmand AI links Dr. Shah to 6 clinical trials. 6 are still active or recruiting. Conditions studied include Heart Valve Diseases, Mitral Valve Insufficiency and Tricuspid Valve Insufficiency. Abbott Medical Devices sponsors the most, 2.

CMS Open Payments shows 297 general payments to Dr. Shah from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Edwards Lifesciences Corporation paid the most, $134,854.

Dr. Shah graduated from Perelman School of Med at the University of Pennsylvania in 1994.